½ÃÀ庸°í¼­
»óǰÄÚµå
1553561

¹Ì±¹ÀÇ ¾Ð¹Ú ¿ä¹ý ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ±â¼úº°, À¯Åë ä³Îº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)

U.S. Compression Therapy Market Size, Share & Trends Analysis Report By Technology (Static Compression Therapy, Dynamic Compression Therapy), By Distribution Channel, By End Use, By Region And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 111 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹Ì±¹ÀÇ ¾Ð¹Ú ¿ä¹ý ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¹Ì±¹ÀÇ ¾Ð¹Ú ¿ä¹ý ½ÃÀåÀº 2030³â±îÁö 18¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ Áß CAGRÀº 2.90%ÀÔ´Ï´Ù.

¸¸¼ºÁ¤¸ÆºÎÀü(CVI)°ú ½ÉºÎÁ¤¸ÆÇ÷ÀüÁõ(DVT)°ú °°Àº ¸¸¼º Á¤¸Æ Áúȯ Áõ°¡À²Àº ¾Ð¹Ú ¿ä¹ý¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¾Ð¹Ú ¿ä¹ýÀº Ç÷¾× ¼øÈ¯À» °³¼±ÇÏ°í ºÎÁ¾À» °¨¼Ò½ÃÅ´À¸·Î½á ÀÌ·¯ÇÑ Áõ»óÀ» °ü¸®ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

¹Ì±¹ ±¹¸³»ý¸í°øÇÐÁ¤º¸¼¾ÅÍ(National Center for Biotechnology Information 2022)¿¡ µû¸£¸é DVT´Â ¹Ì±¹¿¡¼­ 20¸¸ ¸í ÀÌ»óÀÌ ¾Î°í ÀÖ´Â ÁúȯÀÔ´Ï´Ù. ±³À° Ä·ÆäÀΰú °Ç°­ ÁõÁø ±¸»óÀ» ÅëÇØ ¾Ð¹Ú ¿ä¹ýÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¼ÒºñÀÚ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¾Ð¹Ú ¿ä¹ýÀÌ ¾î¶»°Ô Áõ»óÀ» ¿ÏÈ­ÇÏ°í »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ´ÂÁö¿¡ ´ëÇÑ ÀÌÇØ´Â ¾Ð¹Ú ¿ä¹ýÀÇ µµÀÔÀ» ÃËÁøÇÕ´Ï´Ù. ¿¹¹æ ÀÇ·á¿Í Àڱ⠰ü¸®¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¸¸¼ºÁúȯÀ» ¿¹¹æÇÏ°í °ü¸®Çϱâ À§ÇÑ »çÀü ¿¹¹æÃ¥À¸·Î ¾Ð¹Ú ¿ä¹ýÀ» »ç¿ëÇÏ´Â °ÍÀÌ ±ÇÀåµÇ°í ÀÖ½À´Ï´Ù.

ÀçÅÃÄ¡·á ¹× ¿Ü·¡ ȯÀÚ Ä¡·á·ÎÀÇ ÀüȯÀº ÀÓ»ó ÇöÀå ¹Û¿¡¼­ »ç¿ëÇÒ ¼ö ÀÖ´Â ¾Ð¹Ú Ä¡·á Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼¿¡´Â Áö¼ÓÀûÀÎ »óÅ °ü¸®¸¦ À§ÇØ Áý¿¡¼­ ¾Ð¹Úº¹°ú ¾Ð¹Ú±â±¸¸¦ »ç¿ëÇÏ´Â °Íµµ Æ÷ÇԵ˴ϴÙ. ÀçÅÃÄ¡·á ¼­ºñ½º¿Í ¿Â¶óÀÎ ±¸¸Å ¿É¼ÇÀ¸·Î ÀÎÇØ ¾Ð¹Ú ¿ä¹ý Á¦Ç°ÀÌ È¯Àڵ鿡°Ô ´õ¿í Ä£¼÷ÇØÁö°í ÀÖ½À´Ï´Ù. ¾Ð¹Ú ¿ä¹ý Á¦Ç°¿¡ ´ëÇÑ °³¼±µÈ »óȯ Á¤Ã¥ ¹× º¸Çè Àû¿ëÀº ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õÀÇ ÀçÁ¤Àû À庮À» ³·Ãç Á¦Ç° µµÀÔÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÆÒµ¥¹ÍÀº ¾Ð¹Ú Ä¡·á Á¦Ç°À» Æ÷ÇÔÇÑ ÀÇ·á ¿ëǰÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀÌ´Â °è±â°¡ µÇ¾úÀ¸¸ç, COVID-19 ÁßÁõ ȯÀÚ, ƯÈ÷ ÀÔ¿ø ±â°£ÀÌ ±æ¾îÁö°Å³ª ½ÉºÎÁ¤¸ÆÇ÷ÀüÁõ(DVT)°ú °°Àº ÇÕº´ÁõÀ» °æÇèÇÑ È¯ÀÚµéÀº ¾Ð¹Ú Ä¡·á Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄ×½À´Ï´Ù. ÆÒµ¥¹ÍÀº Àü ¼¼°è °ø±Þ¸Á¿¡ Å« È¥¶õÀ» ÀÏÀ¸ÄÑ ¾Ð¹Ú ¿ä¹ý Á¦Ç°ÀÇ »ý»ê°ú À¯Åë¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. °øÀå °¡µ¿ Áß´Ü, °øÀå Æó¼â ¹× ¹è¼Û Áö¿¬À¸·Î ÀÎÇØ ¿øÀÚÀç ¹× ¿ÏÁ¦Ç° ¼ö±Þ¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. COVID-19 °ü·Ã ÇÕº´Áõ ¹× ±âŸ °Ç°­ »óŸ¦ À§ÇÑ »õ·Î¿î ¾Ð¹Ú ¿ä¹ý ¼Ö·ç¼Ç °³¹ß µî ÇコÄÉ¾î ºÐ¾ßÀÇ ¿¬±¸ ¹× °³¹ß ³ë·ÂÀ» °¡¼ÓÈ­Çß½À´Ï´Ù.

¾Ð¹Ú ¿ä¹ý ½ÃÀåÀº ¹Ì±¹ ½ÄǰÀǾ౹(FDA)°ú °°Àº ±â°üÀÇ ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°ÇÀ» ÁؼöÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦¸¦ ÁؼöÇÏ´Â °ÍÀº Á¦Á¶¾÷ü¿¡°Ô µµÀüÀÌ µÉ ¼ö ÀÖ°í ºñ¿ëÀÌ ¸¹ÀÌ µì´Ï´Ù. ½º¸¶Æ® ±â¼úÀ̳ª ¸ÂÃãÇü ÇÇÆÃ°ú °°Àº ÷´Ü ¾Ð¹Ú ¿ä¹ý Á¦Ç°Àº °í°¡ÀÏ ¼ö ÀÖ½À´Ï´Ù. ³ôÀº ºñ¿ëÀ¸·Î ÀÎÇØ ÀϺΠȯÀÚ³ª ÀÇ·á ½Ã¼³¿¡¼­´Â Á¢±ÙÇϱ⠾î·Á¿ï ¼ö ÀÖ½À´Ï´Ù. ¾Ð¹Ú ¿ä¹ý Á¦Ç°¿¡ ´ëÇÑ º¸Çè Àû¿ë ¹× »óȯ Á¤Ã¥Àº Àϰü¼ºÀÌ ¾øÀ¸¸ç, º¸Çè»ç¸¶´Ù Å©°Ô ´Ù¸¦ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Â÷À̴ ȯÀÚ¿¡°Ô °æÁ¦Àû ºÎ´ãÀ» ÁÖ°í ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ½ÃÁß¿¡¼­ ÆÇ¸ÅµÇ´Â ¾Ð¹Ú ¿ä¹ý Á¦Ç°ÀÇ Ç°Áú°ú È¿°ú´Â ´Ù¾çÇÕ´Ï´Ù. Á¦Á¶¾÷üµéÀº ¸ðµç Á¦Ç°ÀÌ ¼º´É°ú ¾ÈÀü¿¡ ´ëÇÑ ³ôÀº ±âÁØÀ» ÃæÁ·ÇØ¾ß ÇÏ´Â °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù.

¹Ì±¹ ¾Ð¹Ú¿ä¹ý ½ÃÀå º¸°í¼­ - ÁÖ¿ä ³»¿ë

  • Á¤Àû ¾Ð¹Ú ¿ä¹ýÀº ¾Ð¹Ú ½ºÅ¸Å·, ½½¸®ºê, ºØ´ë µî ´Ù¾çÇÑ Á¦Ç°±ºÀ¸·Î ÀÎÇØ 2023³â ±â¼ú ºÐ¾ß¿¡¼­ ¿ìÀ§¸¦ Á¡Çß½À´Ï´Ù.
  • Á¤Àû ¾Ð¹Ú ¿ä¹ýÀº ´Ù¾çÇÑ È¯ÀÚÀÇ ¿ä±¸¿Í º´Å¿¡ ´ëÀÀÇÒ ¼ö ÀÖÀ¸¹Ç·Î ½ÃÀå ¿ìÀ§¸¦ Á¡Çϰí ÀÖ½À´Ï´Ù.
  • ÇÑÆí, µ¿Àû ¾Ð¹Ú Ä¡·á ºÐ¾ß´Â °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ÃÖÁ¾ ¿ëµµº°·Î´Â º´¿ø ºÐ¾ß°¡ 2023³â 31.05%ÀÇ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù.
  • 2023³â¿¡´Â ½Ã¼³ ÆÇ¸Å ºÎ¹®ÀÌ ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ȯÀÚ ¼ö°¡ ¸¹±â ¶§¹®¿¡ º´¿ø ¹× ´ë±Ô¸ð Ŭ¸®´Ð°ú °°Àº ½Ã¼³Àº ¾Ð¹Ú ¿ä¹ý Á¦Ç°À» ´ë·®À¸·Î Á¶´ÞÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½Ã¼³ ä³ÎÀ» ÅëÇÑ ¸ÅÃâÀÇ Å« ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ¹Ì±¹ÀÇ ¾Ð¹Ú ¿ä¹ý ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • º¸Á¶ ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
    • ½ÃÀå ±âȸ ºÐ¼®
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦ ºÐ¼®
  • ¹Ì±¹ÀÇ ¾Ð¹Ú ¿ä¹ý ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ¹Ì±¹ÀÇ ¾Ð¹Ú ¿ä¹ý ½ÃÀå : ±â¼úº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ¾Ð¹Ú ¿ä¹ý ½ÃÀåÀÇ º¯µ¿ ºÐ¼®
  • ¹Ì±¹ÀÇ ¾Ð¹Ú ¿ä¹ý ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, 2018-2030³â
  • Á¤Àû ¾Ð¹Ú ¿ä¹ý
  • µ¿Àû ¾Ð¹Ú ¿ä¹ý

Á¦5Àå ¹Ì±¹ÀÇ ¾Ð¹Ú ¿ä¹ý ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ¾Ð¹Ú ¿ä¹ý ½ÃÀåÀÇ º¯µ¿ ºÐ¼®
  • ¹Ì±¹ÀÇ ¾Ð¹Ú ¿ä¹ý ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, 2018-2030³â
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ÀçÅà ÇコÄɾî
  • ÀÇ»ç ¿ÀÇǽº
  • ¾ç·Î¿ø
  • ±âŸ

Á¦6Àå ¹Ì±¹ÀÇ ¾Ð¹Ú ¿ä¹ý ½ÃÀå : À¯Åë ä³Îº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ¾Ð¹Ú ¿ä¹ý ½ÃÀåÀÇ º¯µ¿ ºÐ¼®
  • ¹Ì±¹ÀÇ ¾Ð¹Ú ¿ä¹ý ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, 2018-2030³â
  • ¾÷¹« ÆÇ¸Å
  • ¼Ò¸Å ÆÇ¸Å

Á¦7Àå °æÀï ±¸µµ

  • ½ÃÀå Âü¿© ±â¾÷ÀÇ ºÐ·ù
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Cardinal Health
    • 3M
    • SIGVARIS GROUP
    • Essity
    • Julius Zorn, Inc.
    • HARTMANN USA, Inc
    • Bauerfeind USA Inc.
    • medi USA
    • BIOCOMPRESSION SYSTEMS
    • Gottfried Medical, Inc.
  • È÷Æ®¸Ê ºÐ¼®/±â¾÷ ½ÃÀå ÇöȲ ºÐ¼®
  • 2023³â ±â¾÷ ½ÃÀå Á¡À¯À² ÃßÁ¤ ºÐ¼®
  • ±âŸ ÁÖ¿ä ½ÃÀå ±â¾÷ ¸®½ºÆ®
KSA 24.09.25

U.S. Compression Therapy Market Growth & Trends:

The U.S. compression therapy market is anticipated to reach USD 1.87 billion by 2030, exhibiting a CAGR of 2.90% during the forecast period, according to a new report by Grand View Research, Inc. Rising rates of chronic venous disorders, such as chronic venous insufficiency (CVI) and deep vein thrombosis (DVT), drive demand for compression therapy. Compression therapy helps manage these conditions by improving blood circulation and reducing swelling.

According to the National Center for Biotechnology Information 2022, DVT affects more than 200,000 people in the U.S. Increased awareness about the benefits of compression therapy through educational campaigns and health promotion initiatives drives consumer demand. Understanding how compression therapy can alleviate symptoms and improve quality of life encourages adoption. The growing emphasis on preventive health and self-care encourages the use of compression therapy as a proactive measure to prevent or manage chronic conditions.

The shift towards home healthcare and outpatient care increases the demand for compression therapy products that can be used outside of clinical settings. This trend includes the use of compression garments and devices at home for ongoing condition management. Home healthcare services and online purchasing options make compression therapy products more accessible to patients. Improved reimbursement policies and insurance coverage for compression therapy products help reduce financial barriers for patients and healthcare providers, which facilitates the adoption of these products.

The pandemic led to increased awareness of the importance of medical supplies, including compression therapy products. Patients recovering from severe cases of COVID-19, especially those with extended hospital stays or who experienced complications such as deep vein thrombosis (DVT), have heightened demand for compression therapy. The pandemic caused significant disruptions in global supply chains, affecting the production and distribution of compression therapy products. Lockdowns, factory closures, and shipping delays impacted the availability of raw materials and finished goods. The pandemic accelerated research and development efforts in the healthcare sector, including the development of new compression therapy solutions that address both COVID-19-related complications and other health conditions.

The compression therapy market is subject to stringent regulatory requirements set by organizations such as the Food and Drug Administration. Ensuring compliance with these regulations can be challenging and costly for manufacturers. Advanced compression therapy products, such as those with smart technology or custom fittings, can be expensive. High costs may limit accessibility for some patients and healthcare facilities. Insurance coverage and reimbursement policies for compression therapy products can be inconsistent and vary widely among insurers. This variability can create financial burdens for patients and affect market growth. The quality and effectiveness of compression therapy products available in the market vary. Manufacturers face a challenge in ensuring that all products meet high standards for performance and safety.

U.S. Compression Therapy Market Report Highlights:

  • Static compression therapy dominated the technology segment in 2023 due to the broad range of products, such as compression stockings, sleeves, and bandages.
  • This variety caters to different patient needs and conditions, contributing to its market dominance.
  • On the other hand, the dynamic compression therapy segment is expected to grow at the fastest CAGR.
  • Based on end-use, hospitals segment dominated the market with a share of 31.05% in 2023.
  • In 2023, the institutional sales segment dominated the market in 2023. Due to their high patient volume, institutions such as hospitals and large clinics procure compression therapy products in bulk, which drives significant sales through institutional channels.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Compression Therapy Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Chronic Vein Disorders
      • 3.2.1.2. Growing Number of Orthopedic Procedures
      • 3.2.1.3. Growing Incidence of Obesity
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Alternative Treatment Method
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. U.S. Compression Therapy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Compression Therapy Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Compression Therapy Market Technology Movement Analysis
  • 4.3. U.S. Compression Therapy Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 4.4. Static Compression Therapy
    • 4.4.1. Static Compression Therapy U.S. Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Compression bandages
      • 4.4.2.1. Compression Bandages U.S. Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Compression Stockings
      • 4.4.3.1. Compression Stockings U.S. Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Compression Tape
      • 4.4.4.1. Compression Tape U.S. Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Others Compression Garments
      • 4.4.5.1. Others Compression Garments U.S. Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Dynamic Compression Therapy
    • 4.5.1. Dynamic Compression Therapy U.S. Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Compression Pumps
      • 4.5.2.1. Compression Pumps U.S. Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Compression Sleeves
      • 4.5.3.1. Compression Sleeves U.S. Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Compression Therapy Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Compression Therapy Market Application Movement Analysis
  • 5.3. U.S. Compression Therapy Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals U.S. Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Specialty Clinics
    • 5.5.1. Specialty Clinics U.S. Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Home Healthcare
    • 5.6.1. Home Healthcare U.S. Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Physician's Office
    • 5.7.1. Physician's Office U.S. Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Nursing Homes
    • 5.8.1. Nursing Homes U.S. Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others U.S. Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Compression Therapy Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Compression Therapy Market Technology Type Movement Analysis
  • 6.3. U.S. Compression Therapy Market Size & Trend Analysis, by Technology Type, 2018 to 2030 (USD Million)
  • 6.4. Institutional Sales
    • 6.4.1. Institutional Sales U.S. Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Retail Sales
    • 6.5.1. Retail Sales U.S. Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. Cardinal Health
      • 7.2.1.1. Company Overview
      • 7.2.1.2. Financial Performance
      • 7.2.1.3. Service Benchmarking
      • 7.2.1.4. Strategic Initiatives
    • 7.2.2. 3M
      • 7.2.2.1. Company Overview
      • 7.2.2.2. Financial Performance
      • 7.2.2.3. Service Benchmarking
      • 7.2.2.4. Strategic Initiatives
    • 7.2.3. SIGVARIS GROUP
      • 7.2.3.1. Company Overview
      • 7.2.3.2. Financial Performance
      • 7.2.3.3. Service Benchmarking
      • 7.2.3.4. Strategic Initiatives
    • 7.2.4. Essity
      • 7.2.4.1. Company Overview
      • 7.2.4.2. Financial Performance
      • 7.2.4.3. Service Benchmarking
      • 7.2.4.4. Strategic Initiatives
    • 7.2.5. Julius Zorn, Inc.
      • 7.2.5.1. Company Overview
      • 7.2.5.2. Financial Performance
      • 7.2.5.3. Service Benchmarking
      • 7.2.5.4. Strategic Initiatives
    • 7.2.6. HARTMANN USA, Inc
      • 7.2.6.1. Company Overview
      • 7.2.6.2. Financial Performance
      • 7.2.6.3. Service Benchmarking
      • 7.2.6.4. Strategic Initiatives
    • 7.2.7. Bauerfeind USA Inc.
      • 7.2.7.1. Company Overview
      • 7.2.7.2. Financial Performance
      • 7.2.7.3. Service Benchmarking
      • 7.2.7.4. Strategic Initiatives
    • 7.2.8. medi USA
      • 7.2.8.1. Company Overview
      • 7.2.8.2. Financial Performance
      • 7.2.8.3. Service Benchmarking
      • 7.2.8.4. Strategic Initiatives
    • 7.2.9. BIOCOMPRESSION SYSTEMS
      • 7.2.9.1. Company Overview
      • 7.2.9.2. Financial Performance
      • 7.2.9.3. Service Benchmarking
      • 7.2.9.4. Strategic Initiatives
    • 7.2.10. Gottfried Medical, Inc.
      • 7.2.10.1. Company Overview
      • 7.2.10.2. Financial Performance
      • 7.2.10.3. Service Benchmarking
      • 7.2.10.4. Strategic Initiatives
  • 7.3. Heat Map Analysis/ Company Market Position Analysis
  • 7.4. Estimated Company Market Share Analysis, 2023
  • 7.5. List of Other Key Market Players
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦